Literature DB >> 32960246

Neurology and COVID-19.

S Andrew Josephson1,2, Hooman Kamel3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32960246     DOI： 10.1001/jama.2020.14254

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report.

Authors:  Walaa A Kamel; Ismail Ibrahim Ismail; Mohamed Ibrahim; Jasem Y Al-Hashel
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2021-05-17

2.  Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives.

Authors:  Zachary A Macchi; Roman Ayele; Megan Dini; Jensine Lamira; Maya Katz; Steven Z Pantilat; Jacqueline Jones; Benzi M Kluger
Journal:  Palliat Med       Date:  2021-05-18       Impact factor: 5.713

3.  Severity of Chest Imaging is Correlated with Risk of Acute Neuroimaging Findings among Patients with COVID-19.

Authors:  M Lang; M D Li; K Z Jiang; B C Yoon; D P Mendoza; E J Flores; S P Rincon; W A Mehan; J Conklin; S Y Huang; A L Lang; D M Giao; T M Leslie-Mazwi; J Kalpathy-Cramer; B P Little; K Buch
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-04       Impact factor: 4.966

Review 4.  Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2.

Authors:  Francesca Salamanna; Melania Maglio; Maria Paola Landini; Milena Fini
Journal:  Front Med (Lausanne)       Date:  2020-12-03

5.  Alpha coma in COVID encephalopathy.

Authors:  Marc R Nuwer
Journal:  Clin Neurophysiol       Date:  2020-10-28       Impact factor: 3.708

Review 6.  COVID-19 Legacy.

Authors:  Amit P Ladani; Muruga Loganathan; Murali K Kolikonda; Steven Lippmann
Journal:  South Med J       Date:  2021-12       Impact factor: 0.954

7.  Impact of post-COVID conditions on mental health: a cross-sectional study in Japan and Sweden.

Authors:  Kazuki Matsumoto; Sayo Hamatani; Eiji Shimizu; Anton Käll; Gerhard Andersson
Journal:  BMC Psychiatry       Date:  2022-04-04       Impact factor: 3.630

8.  Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey.

Authors:  Benedetta Bodini; Elena Moro; Joke Jaarsma; Elizabeth Cunningham; Johann Sellner; Donna Walsh
Journal:  Eur J Neurol       Date:  2021-10-05       Impact factor: 6.089

9.  Reversible Cerebral Vasoconstriction Syndrome in the Setting of COVID-19 and Pleomorphic Sarcoma: A Case Report.

Authors:  Ehab Harahsheh; David Gritsch; Amir Mbonde; Michael Apolinario; Joseph M Hoxworth; Bart M Demaerschalk
Journal:  Neurologist       Date:  2022-05-01       Impact factor: 1.524

10.  Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19.

Authors:  Max Borsche; Dirk Reichel; Anja Fellbrich; Anne S Lixenfeld; Johann Rahmöller; Eva-Juliane Vollstedt; Bandik Föh; Alexander Balck; Christine Klein; Marc Ehlers; Andreas Moser
Journal:  Neurol Res Pract       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.